Duration of corticosteroid treatment in hospitalized COVID-19 patients, less is more

DOI QR Code

Marko Lucijanic (Department of Hematology, University Hospital Dubrava) ;
Ivan Papic (Department of Pharmacy, University Hospital Dubrava) ;
Maja Ortner Hadziabdic (Centre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb)

Kim JH, Na YS, Lee SI, et al. Corticosteroid outcome may be dependent of duration of use in severe COVID-19. Korean J Intern Med 2023;38:382-392. https://doi.org/10.3904/kjim.2022.201
Skelin M, Lucijanic M. Longer survival with anti-programmed cell death 1 and development of cutaneous toxic effects, an expected association. JAMA Oncol 2019;5:1642.